Half-year report · Q2
2590.TEDINET S100UB7G
Period2024-01-21 → 2024-07-20
Filed2024-09-03
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥117.6bn | 2024-01-21 → 2024-07-20 | Cons. | Net sales |
| Revenue | ¥213.4bn | 2023-01-21 → 2024-01-20 | Cons. | Net sales (5-year summary) |
| Revenue | ¥101.7bn | 2023-01-21 → 2023-07-20 | Cons. | Net sales |
| Operating income | ¥2.3bn | 2024-01-21 → 2024-07-20 | Cons. | Operating income |
| Operating income | ¥2.5bn | 2023-01-21 → 2023-07-20 | Cons. | Operating income |
| Ordinary income | ¥1.4bn | 2024-01-21 → 2024-07-20 | Cons. | Ordinary income |
| Ordinary income | ¥3.1bn | 2023-01-21 → 2024-01-20 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.8bn | 2023-01-21 → 2023-07-20 | Cons. | Ordinary income |
| Profit before tax | ¥6.5bn | 2024-01-21 → 2024-07-20 | Cons. | Income before income taxes |
| Profit before tax | ¥4.1bn | 2023-01-21 → 2023-07-20 | Cons. | Income before income taxes |
| Net income (owners) | ¥4.9bn | 2024-01-21 → 2024-07-20 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥4.4bn | 2023-01-21 → 2024-01-20 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥2.3bn | 2023-01-21 → 2023-07-20 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥4.7bn | 2024-01-21 → 2024-07-20 | Cons. | Profit loss |
| Net income | ¥2.4bn | 2023-01-21 → 2023-07-20 | Cons. | Profit loss |
| Total assets | ¥199.3bn | at 2024-07-20 | Cons. | Assets |
| Total assets | ¥177.6bn | at 2024-01-20 | Cons. | Assets |
| Total assets | ¥182.1bn | at 2023-07-20 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥105.2bn | at 2024-07-20 | Cons. | Liabilities |
| Total liabilities | ¥86.1bn | at 2024-01-20 | Cons. | Liabilities |
| Net assets / equity | ¥94.2bn | at 2024-07-20 | Cons. | Net assets |
| Net assets / equity | ¥91.5bn | at 2024-01-20 | Cons. | Net assets |
| Net assets / equity | ¥87.8bn | at 2023-07-20 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥36.5bn | at 2024-07-20 | Cons. | Cash and deposits |
| Cash and deposits | ¥32.4bn | at 2024-01-20 | Cons. | Cash and deposits |
| Cash & equivalents | ¥36.3bn | at 2024-07-20 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥33.7bn | at 2024-01-20 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥33.0bn | at 2023-07-20 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥29.2bn | at 2023-01-20d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥5.5bn | 2024-01-21 → 2024-07-20 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥9.2bn | 2023-01-21 → 2024-01-20 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥2.7bn | 2023-01-21 → 2023-07-20 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥4.1bn | 2024-01-21 → 2024-07-20 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥1.2bn | 2023-01-21 → 2024-01-20 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | ¥1.4bn | 2023-01-21 → 2023-07-20 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥1.8bn | 2024-01-21 → 2024-07-20 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥3.2bn | 2023-01-21 → 2024-01-20 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥50m | 2023-01-21 → 2023-07-20 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥155.7 | 2024-01-21 → 2024-07-20 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥140.77 | 2023-01-21 → 2024-01-20 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥74.64 | 2023-01-21 → 2023-07-20 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 46.4% | at 2024-07-20 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 50.4% | at 2024-01-20 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 47.2% | at 2023-07-20 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 46
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2024-01-21 → 2024-07-20 | −¥167m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-01-21 → 2024-07-20 | −¥167m |
| Reconciling Itemsreconciling | segment profit | 2024-01-21 → 2024-07-20 | −¥674m |
| jpcrp040300-q2r_E00424-000Domestic Beverage Businessreportable segment | revenue | 2024-01-21 → 2024-07-20 | ¥73.0bn |
| jpcrp040300-q2r_E00424-000Domestic Beverage Businessreportable segment | revenue external | 2024-01-21 → 2024-07-20 | ¥73.0bn |
| jpcrp040300-q2r_E00424-000Domestic Beverage Businessreportable segment | revenue intersegment | 2024-01-21 → 2024-07-20 | ¥17m |
| jpcrp040300-q2r_E00424-000Domestic Beverage Businessreportable segment | segment profit | 2024-01-21 → 2024-07-20 | −¥238m |
| jpcrp040300-q2r_E00424-000Dy Do Pharmareportable segment | segment profit | 2024-01-21 → 2024-07-20 | −¥295m |
| jpcrp040300-q2r_E00424-000Food Businessreportable segment | revenue | 2024-01-21 → 2024-07-20 | ¥11.1bn |
| jpcrp040300-q2r_E00424-000Food Businessreportable segment | revenue external | 2024-01-21 → 2024-07-20 | ¥11.1bn |
| jpcrp040300-q2r_E00424-000Food Businessreportable segment | revenue intersegment | 2024-01-21 → 2024-07-20 | ¥3m |
| jpcrp040300-q2r_E00424-000Food Businessreportable segment | segment profit | 2024-01-21 → 2024-07-20 | ¥899m |
| jpcrp040300-q2r_E00424-000International Beverage Businessreportable segment | revenue | 2024-01-21 → 2024-07-20 | ¥26.8bn |
| jpcrp040300-q2r_E00424-000International Beverage Businessreportable segment | revenue external | 2024-01-21 → 2024-07-20 | ¥26.8bn |
| jpcrp040300-q2r_E00424-000International Beverage Businessreportable segment | segment profit | 2024-01-21 → 2024-07-20 | ¥2.3bn |
| jpcrp040300-q2r_E00424-000Pharmaceutical Related Businessreportable segment | revenue | 2024-01-21 → 2024-07-20 | ¥6.9bn |
| jpcrp040300-q2r_E00424-000Pharmaceutical Related Businessreportable segment | revenue external | 2024-01-21 → 2024-07-20 | ¥6.7bn |
| jpcrp040300-q2r_E00424-000Pharmaceutical Related Businessreportable segment | revenue intersegment | 2024-01-21 → 2024-07-20 | ¥146m |
| jpcrp040300-q2r_E00424-000Pharmaceutical Related Businessreportable segment | segment profit | 2024-01-21 → 2024-07-20 | ¥324m |
| —segment total | revenue | 2024-01-21 → 2024-07-20 | ¥117.7bn |
| —segment total | revenue external | 2024-01-21 → 2024-07-20 | ¥117.6bn |
| —segment total | revenue intersegment | 2024-01-21 → 2024-07-20 | ¥167m |
| —segment total | segment profit | 2024-01-21 → 2024-07-20 | ¥3.0bn |
| Reconciling Itemsreconciling | revenue | 2023-01-21 → 2023-07-20 | −¥204m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-01-21 → 2023-07-20 | −¥204m |
| Reconciling Itemsreconciling | segment profit | 2023-01-21 → 2023-07-20 | −¥502m |
| jpcrp040300-q2r_E00424-000Domestic Beverage Businessreportable segment | revenue | 2023-01-21 → 2023-07-20 | ¥74.3bn |
| jpcrp040300-q2r_E00424-000Domestic Beverage Businessreportable segment | revenue external | 2023-01-21 → 2023-07-20 | ¥74.2bn |
| jpcrp040300-q2r_E00424-000Domestic Beverage Businessreportable segment | revenue intersegment | 2023-01-21 → 2023-07-20 | ¥19m |
| jpcrp040300-q2r_E00424-000Domestic Beverage Businessreportable segment | segment profit | 2023-01-21 → 2023-07-20 | ¥1.8bn |
| jpcrp040300-q2r_E00424-000Dy Do Pharmareportable segment | segment profit | 2023-01-21 → 2023-07-20 | −¥296m |
| jpcrp040300-q2r_E00424-000Food Businessreportable segment | revenue | 2023-01-21 → 2023-07-20 | ¥10.8bn |
| jpcrp040300-q2r_E00424-000Food Businessreportable segment | revenue external | 2023-01-21 → 2023-07-20 | ¥10.8bn |
| jpcrp040300-q2r_E00424-000Food Businessreportable segment | revenue intersegment | 2023-01-21 → 2023-07-20 | ¥3m |
| jpcrp040300-q2r_E00424-000Food Businessreportable segment | segment profit | 2023-01-21 → 2023-07-20 | ¥776m |
| jpcrp040300-q2r_E00424-000International Beverage Businessreportable segment | revenue | 2023-01-21 → 2023-07-20 | ¥10.5bn |
| jpcrp040300-q2r_E00424-000International Beverage Businessreportable segment | revenue external | 2023-01-21 → 2023-07-20 | ¥10.5bn |
| jpcrp040300-q2r_E00424-000International Beverage Businessreportable segment | segment profit | 2023-01-21 → 2023-07-20 | ¥462m |
| jpcrp040300-q2r_E00424-000Pharmaceutical Related Businessreportable segment | revenue | 2023-01-21 → 2023-07-20 | ¥6.4bn |
| jpcrp040300-q2r_E00424-000Pharmaceutical Related Businessreportable segment | revenue external | 2023-01-21 → 2023-07-20 | ¥6.2bn |
| jpcrp040300-q2r_E00424-000Pharmaceutical Related Businessreportable segment | revenue intersegment | 2023-01-21 → 2023-07-20 | ¥180m |
| jpcrp040300-q2r_E00424-000Pharmaceutical Related Businessreportable segment | segment profit | 2023-01-21 → 2023-07-20 | ¥239m |
| —segment total | revenue | 2023-01-21 → 2023-07-20 | ¥102.0bn |
| —segment total | revenue external | 2023-01-21 → 2023-07-20 | ¥101.7bn |
| —segment total | revenue intersegment | 2023-01-21 → 2023-07-20 | ¥204m |
| —segment total | segment profit | 2023-01-21 → 2023-07-20 | ¥3.0bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 557
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)有限責任 あずさ監査法人 | |
| Cpa1 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)千 田 健 悟 | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)松 川 正 希 | |
| Number of submission | FilingDateInstant | 1 | |
| Net sales (5-year summary) | Prior1YTDDuration | 101746000000 | JPY |
| Net sales (5-year summary) | CurrentYTDDuration | 117578000000 | JPY |
| Net sales (5-year summary) | Prior1YearDuration | 213370000000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YTDDuration | 1773000000 | JPY |
| Ordinary income loss (5-year summary) | CurrentYTDDuration | 1396000000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration | 3115000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YTDDuration | 2343000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | CurrentYTDDuration | 4905000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YearDuration | 4423000000 | JPY |
| Comprehensive income (5-year summary) | Prior1YTDDuration | 1424000000 | JPY |
| Comprehensive income (5-year summary) | CurrentYTDDuration | 3091000000 | JPY |
| Comprehensive income (5-year summary) | Prior1YearDuration | 5384000000 | JPY |
| Net assets (5-year summary) | Prior1QuarterInstant | 87813000000 | JPY |
| Net assets (5-year summary) | CurrentQuarterInstant | 94185000000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant | 91480000000 | JPY |
| Total assets (5-year summary) | Prior1QuarterInstant | 182123000000 | JPY |
| Total assets (5-year summary) | CurrentQuarterInstant | 199348000000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant | 177563000000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1YTDDuration | 74.64 | |
| Basic earnings loss per share (5-year summary) | CurrentYTDDuration | 155.70 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | 140.77 | |
| Diluted earnings per share (5-year summary) | Prior1YTDDuration | － | |
| Diluted earnings per share (5-year summary) | CurrentYTDDuration | － | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | － | |
| Equity to asset ratio (5-year summary) | Prior1QuarterInstant | 0.472 | |
| Equity to asset ratio (5-year summary) | CurrentQuarterInstant | 0.464 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.504 | |
| Net cash provided by used in operating activities (5-year summary) | Prior1YTDDuration | 2685000000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | CurrentYTDDuration | 5500000000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior1YearDuration | 9211000000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YTDDuration | 1358000000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | CurrentYTDDuration | -4120000000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YearDuration | -1240000000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YTDDuration | -50000000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | CurrentYTDDuration | 1810000000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YearDuration | -3212000000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1QuarterInstant | 33030000000 | JPY |
| Cash and cash equivalents (5-year summary) | CurrentQuarterInstant | 36302000000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1YearInstant | 33713000000 | JPY |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 33137000 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 33137000 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 33137000 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 33137000 | |
| Number of shares held | CurrentQuarterInstant_No1MajorShareholdersMember | 4941000 | |
| Shareholding ratio | CurrentQuarterInstant_No1MajorShareholdersMember | 0.1552 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |